Xvivo Perfusion AB 

$6.33
13
+$0.00+0% Monday 17:51

Statistics

Day High
6.54
Day Low
6.54
52W High
7.13
52W Low
4.25
Volume
100
Avg. Volume
2,050
Mkt Cap
199.39M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

22OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.04
0.01
0.07
0.12
Expected EPS
0.0816465
Actual EPS
N/A

Financials

3.31%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
85.26MRevenue
2.82MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XVIPY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap107.36B
Medtronic offers products for cardiac and vascular surgeries, competing in the organ preservation segment.
Boston Scientific
BSX
Mkt Cap66.54B
Boston Scientific competes in the medical devices sector, including technologies for less invasive surgeries.
Stryker
SYK
Mkt Cap126.42B
Stryker provides medical devices for various surgeries, indirectly competing in the organ transplant space.
Intuitive Surgical
ISRG
Mkt Cap144.07B
Intuitive Surgical's robotic-assisted surgical systems can be used in transplant surgeries, offering an alternative to traditional methods.
Edwards Lifesciences
EW
Mkt Cap53.09B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing in the cardiovascular market.
Abbott Laboratories
ABT
Mkt Cap163.61B
Abbott Laboratories offers medical devices, diagnostics, and nutrition products that serve similar patient groups as XVIVO.
Baxter International
BAX
Mkt Cap11.68B
Baxter International provides a range of hospital and renal products, including organ preservation solutions.
Zimmer Biomet
ZBH
Mkt Cap17.67B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, including products that can be used in transplant surgeries.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson's medical devices segment offers products that can be used in various surgeries, including organ transplants.
Danaher
DHR
Mkt Cap140.88B
Danaher Corporation's life sciences and diagnostics segments offer products that can be used in the organ transplant process.

About

Xvivo Perfusion AB (publ), a medical technology enterprise based in Gothenburg, Sweden, specializes in developing cutting-edge solutions for the preservation and perfusion of organs, tissues, and cells, crucial for transplantation. The company's reach spans diverse global markets, including Sweden, the United States, broader North and South America, Europe, the Middle East, Africa, and the Asia Pacific region. Its extensive product lineup features the XVIVO System (XPS), an integrated, ready-to-use cardiac bypass system engineered for secure normothermic ex vivo lung perfusion (EVLP). This is supported by the XPS Disposable Lung Kit, which supplies all necessary sterile consumables. Xvivo Perfusion also provides STEEN Solution, a uniquely formulated buffered extracellular solution for perfusing isolated donor lungs during EVLP procedures. Further offerings include Perfadex Plus, an extracellular, low-potassium, dextran-based electrolyte preservation solution; the XVIVO Silicone Tubing Set for rapid flushing of donor lungs during the procurement phase; and both the XVIVO LS and XVIVO Disposable Lung Set, specialized devices for EVLP. Additionally, the company offers the XVIVO Organ Chamber, a single-use sterile container designed for the temporary holding of isolated lungs before transplantation into a recipient, alongside the XVIVO Lung Cannula Set, another sterile, single-use disposable product. The company was founded in 1998.
Show more...
CEO
Mr. Christoffer Rosenblad
Employees
170
Country
United States
ISIN
US98390P1066

Listings

0 Comments

Share your thoughts

FAQ

What is Xvivo Perfusion AB stock price today?
The current price of XVIPY is $6.33 USD — it has increased by +0% in the past 24 hours. Watch Xvivo Perfusion AB stock price performance more closely on the chart.
What is Xvivo Perfusion AB stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Xvivo Perfusion AB stocks are traded under the ticker XVIPY.
What is Xvivo Perfusion AB market cap?
Today Xvivo Perfusion AB has the market capitalization of 199.39M
When is the next Xvivo Perfusion AB earnings date?
Xvivo Perfusion AB is going to release the next earnings report on October 22, 2026.
What were Xvivo Perfusion AB earnings last quarter?
XVIPY earnings for the last quarter are 0.07 USD per share, whereas the estimation was 0.08 USD resulting in a -13.76% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Xvivo Perfusion AB revenue for the last year?
Xvivo Perfusion AB revenue for the last year amounts to 85.26M USD.
What is Xvivo Perfusion AB net income for the last year?
XVIPY net income for the last year is 2.82M USD.
How many employees does Xvivo Perfusion AB have?
As of July 23, 2026, the company has 170 employees.
In which sector is Xvivo Perfusion AB located?
Xvivo Perfusion AB operates in the Other sector.
When did Xvivo Perfusion AB complete a stock split?
Xvivo Perfusion AB has not had any recent stock splits.
Where is Xvivo Perfusion AB headquartered?
Xvivo Perfusion AB is headquartered in Mölndal, United States.